Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. |
| |
| Authors: | P Aichele D Kyburz P S Ohashi B Odermatt R M Zinkernagel H Hengartner H Pircher |
| |
| Affiliation: | Department of Pathology, University of Zürich, Switzerland. |
| |
| Abstract: | ![]()
A synthetic peptide corresponding to an immunodominant epitope of lymphocytic choriomeningitis virus glycoprotein (LCMV GP) was used to prime or to tolerize CD8+ T cells in vivo, dependent on mode of immunization. Peptide-specific tolerance was then examined in transgenic mice expressing LCMV GP in the beta islet cells of the pancreas; these mice develop CD8+ T-cell-mediated diabetes within 8-14 days after LCMV infection. Specific peptide-induced tolerance prevented autoimmune destruction of beta islet cells and diabetes in this transgenic mouse model. |
| |
| Keywords: | |
|
